BTAIVSVBIO• 6 Months (Normalized)
BTAI vs VBIO (BioXcel Therapeutics Inc. vs Valion Bio Inc.)
Showing Closing Date Range from Mar, 19 to Sep, 15, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BTAI Performance $0.05
+%
BioXcel Therapeutics Inc.
Normalized Baseline0.00%
VBIO Performance $2.15
-90.72%
Valion Bio Inc.
Normalized Baseline0.00%
Alpha Spread Margin BTAI LEADS
+90.72%
BTAI outperforming by 90.72%
BTAIVBIO
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BTAI VBIO
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | BTAI Price | BTAI Gain (%) | VBIO Price | VBIO Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 15, 2026 | $- | $2.15 | -90.72% | - | |
| Sep 14, 2026 | $0.05 | -97.18% | $2.10 | -90.94% | -6.24% |
| Sep 11, 2026 | $0.05 | -96.81% | $2.26 | -90.25% | -6.56% |
| Sep 10, 2026 | $0.05 | -96.88% | $2.20 | -90.51% | -6.37% |
| Sep 09, 2026 | $0.05 | -97.06% | $2.40 | -89.64% | -7.42% |
| Sep 08, 2026 | $0.04 | -97.31% | $2.50 | -89.21% | -8.10% |
| Sep 04, 2026 | $0.07 | -95.38% | $2.77 | -88.05% | -7.33% |
| Sep 03, 2026 | $0.12 | -92.63% | $2.80 | -87.92% | -4.71% |
| Sep 02, 2026 | $0.11 | -93.31% | $3.12 | -86.54% | -6.77% |
| Sep 01, 2026 | $0.14 | -91.44% | $3.07 | -86.75% | -4.69% |
| Aug 31, 2026 | $0.16 | -89.81% | $3.57 | -84.60% | -5.21% |
| Aug 28, 2026 | $0.18 | -88.69% | $3.03 | -86.95% | -1.74% |
| Aug 27, 2026 | $0.72 | -55.06% | $3.08 | -86.73% | +31.67% |
| Aug 26, 2026 | $0.78 | -51.25% | $3.90 | -83.17% | +31.92% |
| Aug 25, 2026 | $0.74 | -53.63% | $3.98 | -82.85% | +29.22% |
Page 1 of 9